SE9301112D0 - A new composition - Google Patents

A new composition

Info

Publication number
SE9301112D0
SE9301112D0 SE19939301112A SE9301112A SE9301112D0 SE 9301112 D0 SE9301112 D0 SE 9301112D0 SE 19939301112 A SE19939301112 A SE 19939301112A SE 9301112 A SE9301112 A SE 9301112A SE 9301112 D0 SE9301112 D0 SE 9301112D0
Authority
SE
Sweden
Prior art keywords
selegiline
pharmaceutically acceptable
acceptable acid
new composition
compositions
Prior art date
Application number
SE19939301112A
Other languages
English (en)
Swedish (sv)
Inventor
Aukusti *Halonen Matti
Inkeri *Leinonen Ulla
Sulevi Lennart *Parhi Seppo
Margareta *Oern Gunilla
Maria *Piippo Ilse
Original Assignee
Orion-Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20389464&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9301112(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion-Yhtymae Oy filed Critical Orion-Yhtymae Oy
Priority to SE19939301112A priority Critical patent/SE9301112D0/xx
Publication of SE9301112D0 publication Critical patent/SE9301112D0/xx
Priority to ES94911961T priority patent/ES2083936T1/es
Priority to PCT/FI1994/000128 priority patent/WO1994022435A1/en
Priority to DE0643578T priority patent/DE643578T1/de
Priority to EP94911961A priority patent/EP0643578A1/en
Priority to AU64300/94A priority patent/AU663995C/en
Priority to NZ263568A priority patent/NZ263568A/en
Priority to FI945716A priority patent/FI945716A0/fi
Priority to CA002137164A priority patent/CA2137164C/en
Priority to EP96110727A priority patent/EP0739628A2/en
Priority to JP6521719A priority patent/JP2752792B2/ja
Priority to NO944631A priority patent/NO944631D0/no
Priority to AU40236/95A priority patent/AU697284B2/en
Priority to US08/774,892 priority patent/US5817336A/en
Priority to AU78418/98A priority patent/AU7841898A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE19939301112A 1993-04-02 1993-04-02 A new composition SE9301112D0 (sv)

Priority Applications (15)

Application Number Priority Date Filing Date Title
SE19939301112A SE9301112D0 (sv) 1993-04-02 1993-04-02 A new composition
EP96110727A EP0739628A2 (en) 1993-04-02 1994-03-31 A new composition containing selegiline
JP6521719A JP2752792B2 (ja) 1993-04-02 1994-03-31 セレジリンを含有する新規組成物
AU64300/94A AU663995C (en) 1993-04-02 1994-03-31 A new composition containing selegiline
CA002137164A CA2137164C (en) 1993-04-02 1994-03-31 A new composition containing selegiline
DE0643578T DE643578T1 (de) 1993-04-02 1994-03-31 Neue zusammensetzung, die selegilin enthält.
EP94911961A EP0643578A1 (en) 1993-04-02 1994-03-31 A new composition containing selegiline
ES94911961T ES2083936T1 (es) 1993-04-02 1994-03-31 Una nueva composicion conteniendo selegilina.
NZ263568A NZ263568A (en) 1993-04-02 1994-03-31 Pharmaceutical composition containing selegiline, (n,alpha-dimethyl-n-2-propynylbenzene-ethanamine)
FI945716A FI945716A0 (fi) 1993-04-02 1994-03-31 Uusi selegiliiniä sisältävä valmiste
PCT/FI1994/000128 WO1994022435A1 (en) 1993-04-02 1994-03-31 A new composition containing selegiline
NO944631A NO944631D0 (no) 1993-04-02 1994-12-01 Sammensetning inneholdende selegilin
AU40236/95A AU697284B2 (en) 1993-04-02 1995-12-06 A new composition containing selegiline
US08/774,892 US5817336A (en) 1993-04-02 1996-12-27 Composition containing selegiline
AU78418/98A AU7841898A (en) 1993-04-02 1998-07-27 A new composition containing selegiline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939301112A SE9301112D0 (sv) 1993-04-02 1993-04-02 A new composition

Publications (1)

Publication Number Publication Date
SE9301112D0 true SE9301112D0 (sv) 1993-04-02

Family

ID=20389464

Family Applications (1)

Application Number Title Priority Date Filing Date
SE19939301112A SE9301112D0 (sv) 1993-04-02 1993-04-02 A new composition

Country Status (8)

Country Link
EP (2) EP0739628A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2752792B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2137164C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE643578T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2083936T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ263568A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE9301112D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1994022435A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5561163A (en) * 1990-08-31 1996-10-01 Deprenyl Animal Health, Inc. Treating hearing loss with deprenyl
ATE199495T1 (de) * 1994-12-14 2001-03-15 Enbalt Trading Ltd Pharmazeutische zubereitung zur direktverpressung
GB9426079D0 (en) * 1994-12-23 1995-02-22 Orion Yhtymae Oy A gelatine capsule
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
DE19743323C2 (de) * 1997-09-30 2000-05-25 Iip Inst Fuer Ind Pharmazie Fo Feste Arzneimittelzusammensetzung auf der Grundlage von Selegilin
DE19814257A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
CA2346069C (en) * 1998-10-07 2008-09-09 Kyowa Hakko Kogyo Co., Ltd. Tablet and tablet production method
US6635278B1 (en) 1998-12-15 2003-10-21 Gilead Sciences, Inc. Pharmaceutical formulations
JP5258144B2 (ja) * 2004-12-21 2013-08-07 株式会社分子生理化学研究所 吸収性の改善された固形状のコエンザイムｑ１０経口製剤の製造方法
DE102012000786A1 (de) * 2012-01-18 2013-07-18 Stada Arzneimittel Ag Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung, enthaltend den Wirkstoff Rasagilin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3137125A (en) * 1962-02-26 1964-06-16 Kyryluk William Frederick Solar motor
US4018543A (en) * 1975-09-19 1977-04-19 The Raymond Lee Organization, Inc. Whirlwind power system
US4224528A (en) * 1979-05-14 1980-09-23 Argo William H Solar thermal and wind energy power source
HU193662B (en) * 1983-12-20 1987-11-30 Chinoin Gyogyszer Es Vegyeszet Process for producing synergetic pharmaceutical composition of antidepressive aktivity
DE3710966A1 (de) * 1986-04-16 1987-12-03 Degussa Synergistische kombination von amantadin und selegilin
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
US4935639A (en) * 1988-08-23 1990-06-19 Yeh Dong An Revolving power tower
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5057321A (en) * 1990-06-13 1991-10-15 Alza Corporation Dosage form comprising drug and maltodextrin
US5300817A (en) * 1993-04-16 1994-04-05 Baird William R Solar venturi turbine

Also Published As

Publication number Publication date
DE643578T1 (de) 1996-09-19
CA2137164A1 (en) 1994-10-13
WO1994022435A1 (en) 1994-10-13
JP2752792B2 (ja) 1998-05-18
AU663995B2 (en) 1995-10-26
CA2137164C (en) 1997-04-08
JPH07506845A (ja) 1995-07-27
ES2083936T1 (es) 1996-05-01
AU6430094A (en) 1994-10-24
EP0643578A1 (en) 1995-03-22
NZ263568A (en) 1996-01-26
EP0739628A2 (en) 1996-10-30
EP0739628A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1996-11-27

Similar Documents

Publication Publication Date Title
IL117356A (en) Controlled release matrix and pharmaceutical compositions for oral administration containing it
WO1997012583A3 (en) Stable compositions containing n-propargyl-1-aminoindan
DK0550108T3 (da) Thyreoaktiv sammensætning med langvarig frigivelse
ATE142104T1 (de) Nichtirritierende zahnpasta
SE9301112D0 (sv) A new composition
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
PT100329A (pt) Composicoes a base de di-hidro-4-(3,5-di-terc-butil-4-hidroxi-benzilideno)-metil-2h-1,2-oxazin-3(4h)-ona sob forma micronizada
IL83086A0 (en) Stable,injectable solutions of vinca dimer salts
NZ332655A (en) Pharmaceutical compositions containing diclofenac and alkali metal bicarbonates
KR890006639A (ko) 벤조티아진 디옥사이드 유도체
ATE163265T1 (de) Asserlösliche pharmazeutische zusammensetzungen, die östronderivate und kalziumsalze enthalten
GB2258397A (en) Pharmaceutical compositions containing amethocaine
ATE127343T1 (de) Pharmazeutische zubereitung von roxindol oder carmoxirol mit vorgeqüollener stärke.
DK0524696T3 (da) Orale præparater indeholdende dapiprazol
IT1274483B (it) Composizioni farmaceutiche contenenti gemfibrozil
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
IT1224250B (it) Associzione del depiprazolo con la morfina
BR9304493A (pt) Soluçóes de etilato de magnésio carbonatado, estáveis a armazenamento, processo para sua preparaçáo dessas soluçóes
ATE5634T1 (de) Synergistische blutdrucksenkende zusammensetzungen.
KR960705565A (ko) 테르페나딘과 이부프로펜의 안정한 약제학적 조성물(A stable pharmaceuitical composition of terfenadine and ibuprofen)
EP0127389A3 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
KR860002498A (ko) 1,4-디하이드로피리딘 유도체의 약학조성물
KR950016755A (ko) 간염의 예방 및 치료용 의약조성물
GB8829478D0 (en) Formulations
MX166479B (es) Composicion farmaceutica que contiene carbinolimidazoles